DR-TB HIV Coordinator: NTEP
Fullscreen
Content
- End TB strategy
- Sustainable Development Goals [SDGs] related to TB
- Evolution of TB Elimination Programme in India
- India's commitment to End TB
- National Strategic Plan [NSP] for TB Elimination 2017-25
- NTEP Objectives- in relation to NSP 2017-2025
- Standards of TB Care in India
- History of Programmatic Management of Drug Resistant TB in India
- Organizational Structure of NTEP
- District TB Centre [DTC]
- Tuberculosis Unit
- Peripheral Health Institutions [PHI] and Health Facilities
- TB Arogya Saathi Application
DR-TB HIV Coordinator: TB Infection treatment and care
Fullscreen
Content
- Testing for TB Infection
- TB Preventive Therapy
- Eligibility for TPT
- Cascade of Care for TPT
- Approaches for TPT implementation
- Counselling for IGRA/TST
- Counselling for TPT
- Monitoring adherence to TPT
- Preventive Treatment for Contacts of DR-TB Patients: WHO Recommendations
- Screening among Household Contacts of DR-TB Patients
DR-TB HIV Coordinator: Monitoring and Review
Fullscreen
Content
- Monitoring and Evaluation
- Program Monitoring Indicators
- Nine NTEP Performance Indicators
- TB Performance Indicator - Percentage of Target TB Notification Achieved
- Root cause analysis for low performance- suggested solutions- case studies along 1
- TB Performance Indicator - Percentage of TB Notified Patients with Known HIV Status
- Root cause analysis for low performance of Percentage of TB Notified Patients with Known HIV Status
- TB Performance Indicator - Percentage of TB Notified Patients with Universal Drug Susceptibility Testing (UDST) Done
- Root cause analysis for low performance of Percentage of TB Notified Cases with Universal Drug Susceptibility Testing Done
- TB Performance Indicator - Percentage of TB Notified Patients with Universal Drug Susceptibility Testing (UDST) Done
- Root cause analysis for low performance- suggested solutions- case studies along 6
- Performance Indicator - Percentage of People Living with HIV (PLHIV) given INH Preventive Treatment (IPT) Against Total Eligible PLHIV
- Root cause analysis for low performance- suggested solutions- case studies along 9
- PMDT Review Mechanisms
- Internal Evaluation
DR-TB HIV Coordinator: Longer Oral M/XDR-TB Regimen
Fullscreen
Content
- Longer Oral M/XDR-TB: Regimen and Duration
- Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen
- Treatment Extension in Longer Oral M/XDR-TB Regimen
- Dosages of M/XDR-TB Drugs for Adult in Longer Oral M/XDR-TB Regimen
- Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
- Details of Replacement Sequence of Drugs in Longer Oral M/XDR-TB Regimen
DR-TB HIV Coordinator: TB and HIV Collaborative Activities
Fullscreen
Content
- National TB-HIV Collaborative Framework
- Overview of TB-HIV Collaborative Activities under NTEP
- NACP and NTEP Coordination at National, State and District Levels
- State AIDS Control Society [SACS]
- District AIDS Prevention and Control Units [DAPCU]
- Linkage to TB-HIV services in the private sector
- Advocacy to affected communities and PLHA networks
- HIV testing of presumptive TB cases and TB patients
- Tuberculosis Health Action Learning Initiative [THALI]
DR-TB HIV Coordinator: DR-TB Treatment and care
Fullscreen
Content
- Drug-Resistant Tuberculosis(DR-TB)
- Types of Drug Resistance Tuberculosis -DRTB
- Goals of DR-TB Treatment
- Newer Anti-TB Drugs
- Weight Band-wise Dosages of DR-TB Drugs for Adults
- Treatment of DR-TB in Children
- DR-TB Treatment Care Cascade
- Pre-treatment Counselling of DR-TB Patients
- Pre treatment evaluation of a DRTB cases
- DR-TB Treatment – Patient Flow
- Second Line anti TB drugs
- DR-TB Treatment Regimens
- Treatment Algorithm for MDR/RR-TB
- Management of M/XDR-TB Treatment During Pregnancy
- DR-TB Treatment in Pregnancy: Recommendation for the Use of Contraception
- Follow-up Monitoring of DR-TB Patients
- Rehabilitation service to TB patients
- Palliative Care in DR-TB
- Need for Palliative Care in DR-TB Patients
- Interim Treatment Outcomes of DR-TB Cases
- Final Treatment Outcomes of DR-TB Cases
- Interim reports of DR-TB Treatment
- PMDT Report
DR-TB HIV Coordinator: DBT
Fullscreen
Content
- Direct Benefit Transfer(DBT) under NTEP
- Stakeholders/Systems for DBT under NTEP
- DBT Schemes in NTEP
- Other Local DBT Schemes
- Criteria for availing DBT Scheme benefits under NPY
- Transport Support for TB Patients in Notified Tribal Areas
- Treatment Supporter Honorarium Eligibility
- Incentives for Private Providers and Informants
DR-TB HIV Coordinator: General concepts in TB Treatment
Fullscreen
Content
- Goals of treatment
- Strategies for TB Treatment
- Pharmacological Basis of treatment
- Treatment Phases
- Fixed Dose Combinations [FDC]s
- Advantages of FDCs
- FDCs used in NTEP
- TB Drug Regimen
- TB Treatment Initiation
- TB patient follow up
- TB Treatment Outcome
- Adverse Event Definitions and Classifications
- Classification of Adverse Drug Events
- Types of ADR of TB Treatment
- Management of Adverse Drug Reactions(ADRs) of TB Treatment
- Follow up sputum examination
- TB Treatment Card
- NTEP TB ID Card
- PMDT Treatment Book
- DRTB Treatment Register
- Transfer of TB Patient
- Treatment Support Plan
- Management of EPTB
- Management of Patients with Treatment Interruptions
- Management of TB in special situations
- Death Audit